Anteris Technologies Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
79
- Stock Symbol
-
AVR
- Investments
-
6
- Share Price
-
$12.77
- (As of Friday Closing)
Anteris Technologies General Information
Description
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.
Contact Information
- PO Box 1159
- Milton, Queensland 4064
- Australia
Anteris Technologies Timeline
Anteris Technologies Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.77 | $12.91 | $11.75 - $18.91 | $221M | 17.3M | 9.7K |
Anteris Technologies Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 193,932 | 188,827 | 92,938 | 17,515 |
| Revenue | 3,179 | 5,844 | 6,353 | |
| EBITDA | (28,971) | (15,100) | (9,401) | |
| Net Income | (30,710) | (17,184) | (10,506) | |
| Total Assets | 15,973 | 21,372 | 9,727 | |
| Total Debt | 957 | 4,153 | 2,909 |
Anteris Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anteris Technologies Comparisons
Industry
Financing
Details
000000
000000
Anteris Technologies Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Colibri Heart Valve | Venture Capital-Backed | Louisville, CO | 0 | 00.00 | 00000000000 | 00.00 |
| 00000000 000000000 | Formerly PE-Backed | Lewisville, TX | 0000 | 00000 | 000000000 00 | 00000 |
| 0000000 0000000000 | Corporate Backed or Acquired | Lane Cove West, Australia | 0000 | 00.000 | 000000000 | 00.000 |
| 00000 | Formerly VC-backed | Columbia, MD | 000 | 000.00 | 000000&0 | 000.00 |
Anteris Technologies Executive Team (15)
Anteris Technologies Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000000 | Self | Non-Executive Director & Chairman | 000 0000 |
Anteris Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Anteris Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Anteris Technologies Investments & Acquisitions (6)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Admedus Biomanufacturing | 31-Dec-2013 | 0000000000 | Other Pharmaceuticals and Biotechnology | 0000 0000 | |
| Genzyme Australasia (Manufacturing site in Malaga) | 31-Dec-2013 | 000000000 | Buildings and Property | 000 00000 | |
| Coridon | 01-Jul-2013 | 000000000 | Biotechnology | ||
| Coridon | 27-Apr-2012 | 000000000 | Biotechnology | 000 00000 | |
| bioMD | 29-Jun-2011 | Merger/Acquisition | 000.00 | Surgical Devices | 000 00000 |
Anteris Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Supplies
Subindustry
Rank
Percentile
